# The Possible Effects of Roflumilast on Obesity Related Disorders

> **NCT04800172** · PHASE3 · COMPLETED · sponsor: **Tanta University** · enrollment: 66 (actual)

## Conditions studied

- Obesity
- PreDiabetes

## Interventions

- **DRUG:** Roflumilast
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT04800172
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-01
- **Primary completion:** 2022-03-31
- **Final completion:** 2022-03-31
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2022-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04800172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04800172, "The Possible Effects of Roflumilast on Obesity Related Disorders". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04800172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*